Table 2. Clinical and laboratory characteristics of patients with paracoccidioidomycosis caused by P. lutzii at the time of diagnosis.

Characteristic		n	%
Admission	New Case	30	88.2
	Recurrence	4	11.8
Clinical form	Chronic	34	100.0
	Other	0	-
Classification	Multifocal	30	88.2
	Unifocal	4	11.8
Affected Sites	Lung	28	82.4
	Lymph nodes	23	67.7
	Mouth	19	55.9
	Skin	16	47.1
	Larynx	11	32.8
	Nose	4	11.8
	Bone	4	11.8
	Adrenal glands	1	2.9
Duration of symptoms	1–6	13	39.4
(months)	7–12	8	24.2
	> 12	12	36.4
Diagnostic method	Culture	33	97.1
	Direct mycological examination	30	88.2
	Histopathological examination	12	35.3
Clinical Specimen	Lymph node aspiration	14	41.2
	Oral lesion scraping	13	38.2
	Sputum	3	8.8
	Skin fragment	3	8.8
	Blood	1	3.0
Drugs used for the treatment	SMX+TMP	30	88.2
	SMX+TMP and itraconazole	7	20.5
	Itraconazole	2	5.9
	Amphotericin B	2	5.9
		Mean (SD)
Hematology/Biochemistry	Hemoglobin (g/dL)	11.7 (2.6)
	Hematocrit (%)	36.6 (7.1)
	Leukocytes (/mm3)	10,284 (3,947)
	Eosinophils (/mm3)	544 (500)
	Albumin (g/dL)	3.2 (0.6)
	Glucose (g/dL)	90.9 (21.1)

SD: standard deviation

SMX+TMP: sulfamethoxazole + trimethoprim